Howdeshell Kembra L, Furr Johnathan, Lambright Christy R, Rider Cynthia V, Wilson Vickie S, Gray L Earl
North Carolina State University, Department of Molecular Biomedical Sciences, Raleigh, North Carolina 27606, USA.
Toxicol Sci. 2007 Sep;99(1):190-202. doi: 10.1093/toxsci/kfm069. Epub 2007 Mar 30.
Exposure to plasticizers di(n-butyl) phthalate (DBP) and diethylhexyl phthalate (DEHP) during sexual differentiation causes male reproductive tract malformations in rats and rabbits. In the fetal male rat, these two phthalate esters decrease testosterone (T) production and insulin-like peptide 3 (insl3) gene expression, a hormone critical for gubernacular ligament development. We hypothesized that coadministered DBP and DEHP would act in a cumulative dose-additive fashion to induce reproductive malformations, inhibit fetal steroid hormone production, and suppress the expression of insl3 and genes responsible for steroid production. Pregnant Sprague Dawley rats were gavaged on gestation days (GD) 14-18 with vehicle control, 500 mg/kg DBP, 500 mg/kg DEHP, or a combination of DBP and DEHP (500 mg/kg each chemical; DBP+DEHP); the dose of each individual phthalate was one-half of the effective dose predicted to cause a 50% incidence of epididymal agenesis. In experiment one, adult male offspring were necropsied, and reproductive malformations and androgen-dependent organ weights were recorded. In experiment two, GD18 testes were incubated for T production and processed for gene expression by quantitative real-time PCR. The DBP+DEHP dose increased the incidence of many reproductive malformations by >or=50%, including epididymal agenesis, and reduced androgen-dependent organ weights in cumulative, dose-additive manner. Fetal T and expression of insl3 and cyp11a were cumulatively decreased by the DBP+DEHP dose. These data indicate that individual phthalates with a similar mechanism of action, but with different active metabolites (monobutyl phthalate versus monoethylhexyl phthalate), can elicit dose-additive effects when administered as a mixture.
在性分化期间接触增塑剂邻苯二甲酸二丁酯(DBP)和邻苯二甲酸二(2-乙基己基)酯(DEHP)会导致大鼠和兔子出现雄性生殖道畸形。在雄性胎鼠中,这两种邻苯二甲酸酯会降低睾酮(T)的产生以及胰岛素样肽3(insl3)的基因表达,insl3是一种对睾丸引带发育至关重要的激素。我们推测,联合给予DBP和DEHP会以累积剂量相加的方式发挥作用,诱导生殖畸形,抑制胎儿类固醇激素的产生,并抑制insl3以及负责类固醇产生的基因的表达。在妊娠第14至18天,给怀孕的斯普拉格-道利大鼠灌胃给予溶剂对照、500 mg/kg DBP、500 mg/kg DEHP或DBP与DEHP的混合物(每种化学物质500 mg/kg;DBP + DEHP);每种邻苯二甲酸酯的剂量是预计导致附睾发育不全发生率达50%的有效剂量的一半。在实验一中,对成年雄性后代进行尸检,并记录生殖畸形和雄激素依赖器官的重量。在实验二中,将妊娠第18天的睾丸进行孵育以检测T的产生,并通过定量实时PCR进行基因表达分析。DBP + DEHP剂量使许多生殖畸形的发生率增加了≥50%,包括附睾发育不全,并以累积、剂量相加的方式降低了雄激素依赖器官的重量。DBP + DEHP剂量使胎儿T以及insl3和cyp11a的表达累积性降低。这些数据表明,具有相似作用机制但活性代谢物不同(邻苯二甲酸单丁酯与邻苯二甲酸单(2-乙基己基)酯)的单个邻苯二甲酸酯作为混合物给药时可产生剂量相加效应。